After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'
Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose...To view the full article, register now.
Already a subscriber? Click here to view full article